Stay updated on Pembrolizumab for Desmoplastic Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Desmoplastic Melanoma Clinical Trial page.

Latest updates to the Pembrolizumab for Desmoplastic Melanoma Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRevision history updated: added v3.5.2 with entries for 2026-04-09 and 2026-04-13, and removed entries for v3.5.0 dated 2026-04-07 and 2026-04-08.SummaryDifference0.1%

- Check18 days agoChange Detected- The study page history shows additions of 2026-04-07 and 2026-04-08 and deletions of 2026-03-31 and 2026-04-01, reflecting update history.SummaryDifference0.0%

- Check26 days agoChange DetectedTwo dates (2026-04-01 and 2026-03-31) were added and two dates (2026-03-24 and 2026-03-21) were removed from the Study Record Dates.SummaryDifference0.0%

- Check33 days agoChange DetectedRevision log updated to v3.5.0 with new timestamps (2026-03-21 and 2026-03-24), replacing the previous v3.4.3.SummaryDifference0.1%

- Check40 days agoChange DetectedStudy record dates show additions on 2026-03-14 and 2026-03-17, and deletions on 2026-03-07 and 2026-03-10.SummaryDifference0.0%

- Check48 days agoChange DetectedThe Publications section was updated to replace the online-ahead-of-print Nat Cancer citation with the finalized Nat Cancer article (SWOG S1512 cohort A) and update its bibliographic details. The update also notes the 2026-03-10 entry date and revision to v3.4.3.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab for Desmoplastic Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Desmoplastic Melanoma Clinical Trial page.